E. McSpadden

Severe morbidity among hospitalised adults with acute influenza and other respiratory infections: 2014–2015 and 2015–2016

A. Monto, A. Lauring, J. Petrie, 2018, Epidemiology and Infection.

Evaluation of correlates of protection against influenza A(H3N2) and A(H1N1)pdm09 infection: Applications to the hospitalized patient population

M. Eichelberger, A. Monto, Caroline K. Cheng, 2018, bioRxiv.

Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021

David W. McDonald, Meghan A. Wallace, Joel D. Levitt, 2021, MMWR. Morbidity and mortality weekly report.

Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021

David W. McDonald, Meghan A. Wallace, Joel D. Levitt, 2021, MMWR. Morbidity and mortality weekly report.

Prevention of influenza hospitalization among adults in the US, 2015-16: Results from the US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).

D. Pakstis, A. Monto, Xiyan Xu, 2018, The Journal of infectious diseases.

Severe morbidity among hospitalised adults with acute influenza and other respiratory infections: 2014–2015 and 2015–2016

A. Monto, A. Lauring, J. Petrie, 2018, Epidemiology and Infection.

Effectiveness of Influenza Vaccine for Preventing Laboratory-Confirmed Influenza Hospitalizations in Immunocompromised Adults

A. Monto, Xiyan Xu, A. Arroliga, 2020, medRxiv.